These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Phenotypic and functional characterization of recombinant interleukin 2 (rIL 2)-induced activated killer cells: analysis at the population and clonal levels. Ferrini S, Miescher S, Zocchi MR, von Fliedner V, Moretta A. J Immunol; 1987 Feb 15; 138(4):1297-302. PubMed ID: 3100633 [Abstract] [Full Text] [Related]
4. Lymphokine-activated killer activity in long-term cultures with anti-CD3 plus interleukin 2: identification and isolation of effector subsets. Ochoa AC, Hasz DE, Rezonzew R, Anderson PM, Bach FH. Cancer Res; 1989 Feb 15; 49(4):963-8. PubMed ID: 2521457 [Abstract] [Full Text] [Related]
5. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells. Vujanovic NL, Herberman RB, Olszowy MW, Cramer DV, Salup RR, Reynolds CW, Hiserodt JC. Cancer Res; 1988 Feb 15; 48(4):884-90. PubMed ID: 3257412 [Abstract] [Full Text] [Related]